Insider Transactions in Q4 2021 at Tracon Pharmaceuticals, Inc. (TCON)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
52,325
+3.66%
|
$104,650
$2.51 P/Share
|
|
Dec 28
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,125
+3.28%
|
$40,250
$2.63 P/Share
|
|
Dec 27
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
87,325
+3.63%
|
$174,650
$2.92 P/Share
|
|
Dec 15
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,964
+0.78%
|
$43,928
$2.43 P/Share
|
|
Dec 14
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
42,000
+2.05%
|
$84,000
$2.53 P/Share
|
|
Dec 13
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,204
+0.53%
|
$30,408
$2.64 P/Share
|
|
Dec 06
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,733
+0.96%
|
$45,466
$2.26 P/Share
|
|
Dec 03
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
89,274
+3.46%
|
$178,548
$2.3 P/Share
|
|
Dec 02
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,500
+0.32%
|
$21,000
$2.35 P/Share
|
|
Dec 01
2021
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+2.01%
|
$100,000
$2.4 P/Share
|
|
Nov 19
2021
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
3,500
+1.57%
|
$7,000
$2.82 P/Share
|
|
Nov 18
2021
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
681
+0.31%
|
$1,362
$2.88 P/Share
|
|
Nov 05
2021
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+0.92%
|
$12,000
$3.42 P/Share
|